After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
The company is listed on the NASDAQ and operates within the Biotechnology industry segment. The current market capitalization of Moderna Inc is $15.76B. A total of 2.52 million shares were traded on the day, compared to an average of 7.52M shares.
In the most recent transaction, Klinger Shannon Thyme sold 529 shares of MRNA for 44.68 per share on Dec 09 ’24. After the transaction, the Chief Legal Officer now owns 20,446 company shares. In a previous transaction on Dec 09 ’24, Klinger Shannon Thyme bought 529 shares at 44.68 per share.
Among the insiders who sold shares, Klinger Shannon Thyme disposed of 112 shares on Dec 03 ’24 at a per-share price of $43.30. This resulted in the Chief Legal Officer holding 19,837 shares of MRNA after the transaction. In another insider transaction, Hoge Stephen sold 314 shares at $43.30 per share on Dec 03 ’24. Company shares held by the President now total 1,443,904.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, MRNA has a high of $170.47 and a low of $35.80.
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. MRNA’s latest balance sheet shows that the firm has $10.73B in Cash & Short Term Investments as of fiscal 2021. There were $916.00M in debt and $9.13B in liabilities at the time. Its Book Value Per Share was $30.98, while its Total Shareholder’s Equity was $14.14B.
Analysts Opinion
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for MRNA is Buy with a score of 3.12.
